Alone we can do little, but together we can do much.

Immunotherapies work by retraining the immune system, and scientists hope they can stop or prevent the immune attack behind Type 1 diabetes. Clinical trials testing immunotherapies are going on right ...

Some people with type 2 diabetes might have differences in how their brains get messages about sweet flavours. Dr Sally Eldeghaidy wants to find out more about why this is, by looking for signals in ...

Tiny variations in our genes can affect insulin receptors, which sit on the surface of our cells and allow insulin to enter. Problems with insulin receptors affect how our body responds to insulin and ...

In this series we take a look at some of the exciting diabetes research developments announced recently, and what the findings could mean for people living with or affected by diabetes. We bring to ...

Find out how we fund and shape diabetes research, putting what matters most to people with diabetes at the top of the agenda. Plus, explore 100+ research projects we’re supporting now. Diabetes ...

What you eat can affect how well you feel and how you manage your diabetes. Although there's no such thing as a diabetes diet or food plan, we've put together advice to help you make healthier choices ...

We’re thrilled that 20,000 children have signed up to the ELSA (EarLy Surveillance for Autoimmune diabetes) study to understand their future risk of type 1 diabetes. Recruitment is still open and ...

Looking to try something new? We’ve got loads of recipes to choose from. All our recipes have been checked and approved by a specialist team of dietitians, so you’ll always know what’s in your food.

In our September research highlights, we look at studies presented at the annual European Association for the Study of Diabetes (EASD) conference in September, including how voice screening could be ...

The NHS continues to face supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...